Hbk Sorce Advisory LLC Amgen Inc Transaction History

Hbk Sorce Advisory LLC

$2.56 Billion
Q3 2024

A detailed history of Hbk Sorce Advisory LLC transactions in Amgen Inc stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 12,684 shares of AMGN stock, worth $3.74 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

12,684

Previous 12,958 2.11%

Holding current value

$3.74 Million

Previous $4.05 Million 0.94%

% of portfolio

0.16%

Previous 0.15%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $84,770 - $92,442	-274 Reduced 2.11%	12,684 $4.09 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $204,945 - $249,061	780 Added 6.4%	12,958 $4.05 Million
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $8,334 - $10,061	31 Added 0.26%	12,178 $3.46 Million
Q4 2023 Jan 25, 2024	SELL	$255.7 - $288.46 $45,770 - $51,634	-179 Reduced 1.45%	12,147 $3.5 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $141,685 - $175,906	648 Added 5.55%	12,326 $3.31 Million
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $2.92 Million - $3.45 Million	-13,630 Reduced 53.86%	11,678 $2.59 Million
Q1 2023 Aug 15, 2023	BUY	$225.79 - $275.2 $169,794 - $206,950	752 Added 6.44%	12,430 $3 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $345,910 - $421,606	-1,532 Reduced 5.71%	25,308 $9.23 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $2.65 Million - $3.37 Million	11,581 Added 75.9%	26,840 $7.05 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $132,880 - $149,864	592 Added 4.04%	15,259 $3.44 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $59,523 - $66,238	258 Added 1.79%	14,667 $3.57 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $322,765 - $357,063	1,472 Added 11.38%	14,409 $3.48 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $195,896 - $224,186	985 Added 8.24%	12,937 $2.91 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $209,298 - $245,218	-986 Reduced 7.62%	11,952 $2.54 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $18,219 - $20,212	-78 Reduced 0.6%	12,938 $3.15 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $89,651 - $104,474	404 Added 3.2%	13,016 $3.24 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $362,003 - $431,081	1,673 Added 15.29%	12,612 $2.9 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $189,831 - $211,108	-809 Reduced 6.89%	10,939 $2.78 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $53,210 - $65,297	-269 Reduced 2.24%	11,748 $2.77 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $25,513 - $33,838	140 Added 1.18%	12,017 $2.44 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $321,089 - $412,710	1,697 Added 16.67%	11,877 $2.86 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $5,919 - $7,093	-34 Reduced 0.33%	10,180 $1.97 Million
Q2 2019 Aug 15, 2019	BUY	$166.7 - $195.41 $1.06 Million - $1.24 Million	6,362 Added 165.16%	10,214 $1.88 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $1.06 Million - $1.25 Million	-6,374 Reduced 62.33%	3,852 $586,000
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $106,894 - $120,493	591 Added 6.13%	10,226 $1.94 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $10,704 - $12,495	60 Added 0.63%	9,635 $1.88 Million
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $11,858 - $13,368	64 Added 0.67%	9,575 $1.98 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $122,046 - $137,084	735 Added 8.38%	9,511 $0
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $155,875 - $182,160	920 Added 11.71%	8,776 $1.5 Million
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $716,175 - $800,187	4,243 Added 117.44%	7,856 $1.37 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $604,418 - $690,083	3,613	3,613 $674,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.

Account

Hbk Sorce Advisory LLC Amgen Inc Transaction History